Table 3.
Histologic diagnosis | N | HPV 16 | HPV 18 | HPV 33 | HPV 52 | HPV 58 | Other nine | HR-HPV* |
---|---|---|---|---|---|---|---|---|
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||
Total | 393 | 43 (11.0) | 12 (3.1) | 10 (2.5) | 46 (11.7) | 36 (9.2) | 74 (18.8) | 142 (36.1) |
Normal | 351 | 24 (6.8) | 7 (2.0) | 7 (2.0) | 36 (10.3) | 29 (8.3) | 61 (17.4) | 109 (31.1) |
CIN1 | 13 | 2 (15.4) | 1 (7.7) | 1 (7.7) | 1 (7.7) | 0 (0.0) | 3 (23.1) | 5 (38.5) |
CIN2 | 10 | 4 (40.0) | 1 (10.0) | 0 (0.0) | 3 (30.0) | 4 (40.0) | 3 (30.0) | 9 (90.0) |
CIN3 | 19 | 13 (68.4) | 3 (15.8) | 2 (10.5) | 6 (31.6) | 3 (15.8) | 7 (36.8) | 19 (100.0) |
HPV, human papillomavirus; CIN, cervical intraepithelial neoplasia; CIN2+, cervical intraepithelial neoplasia grade 2 or worse; HR-HPV, high risk-human papillomavirus, other nine including HPV types 31, 35, 39, 45, 51, 56, 59, 66, 68;
including HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68.